cannabis orally disintegrating tablet (MGC-ODT) / OWC Pharma - LARVOL DELTA

OWC Pharmaceutical Research Corp. to report top line results (TLR) for a safety study on its cannabis-based tablets (BioSpace) - "OWC Pharmaceutical Research Corp...announced today that...One World Cannabis Ltd., a company organized and existing under the laws of Israel and a wholly-owned subsidiary of OWC received Top Line Results (TLR) of its single-dose, randomized, crossover study to compare the safety, tolerability and pharmacokinetics (PK) of OWC's Medical Grade Cannabis - Orally Disintegrating Tablets (MGC-ODT) vs. buccal Sativex®, in healthy adult volunteers...The results indicated dose-related comparability of both products in rate of absorption and bioavailability. The incidence of treatment related adverse events (AEs) were similar between the treatments."

PK/PD data

Comparison of Safety, Tolerability and Pharmacokinetics of Medical Grade Cannabis (MGC) Orally Disintegrating Tablets With Buccal Sativex®, in Healthy Adult Volunteers (clinicaltrials.gov) - P1; N=16; Completed; Sponsor: One World Cannabis Ltd.; Recruiting ➔ Completed

Clinical • Trial completion